CERS4 c.-2+1967A>G

Variant ID: 19-8277713-A-G

NM_024552.3(CERS4):c.-2+1967A>G

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.

Communications Biology
Baloni, Priyanka P; Arnold, Matthias M; Buitrago, Luna L; Nho, Kwangsik K; Moreno, Herman H; Huynh, Kevin K; Brauner, Barbara B; Louie, Gregory G; Kueider-Paisley, Alexandra A; Suhre, Karsten K; Saykin, Andrew J AJ; Ekroos, Kim K; Meikle, Peter J PJ; Hood, Leroy L; Price, Nathan D ND; , ; Doraiswamy, P Murali PM; Funk, Cory C CC; Hernández, A Iván AI; Kastenmüller, Gabi G; Baillie, Rebecca R; Han, Xianlin X; Kaddurah-Daouk, Rima R
Publication Date: 2022-10-08

Variant appearance in text: rs12610250
PubMed Link: 36209301
Variant Present in the following documents:
  • 42003_2022_4011_MOESM1_ESM.pdf
View BVdb publication page



Diminished Sphingolipid Metabolism, a Hallmark of Future Type 2 Diabetes Pathogenesis, Is Linked to Pancreatic β Cell Dysfunction.

Iscience
Khan, Saifur R SR; Manialawy, Yousef Y; Obersterescu, Andreea A; Cox, Brian J BJ; Gunderson, Erica P EP; Wheeler, Michael B MB
Publication Date: 2020-10-23

Variant appearance in text: rs12610250
PubMed Link: 33103069
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page